Sanofi Overview
Sanofi is a Paris-based biopharmaceutical company with FY2025 net sales of EUR43.626 billion and 74,846 employees. It operates across specialty medicines, vaccines, rare diseases, and general medicines, and is moving toward a more focused science-led model under CEO Belen Garijo.
How Sanofi Makes Money
Sanofi makes money by discovering, developing, manufacturing, and selling prescription medicines and vaccines through direct sales teams, hospital channels, wholesalers, pharmacies, and government procurement programs. Major revenue drivers include specialty medicines such as Dupixent, rare disease therapies, vaccines, and established general medicines.
Sanofi Financials
Sanofi reported EUR43.626 billion of FY2025 net sales, compared with EUR41.081 billion in FY2024 and EUR37.817 billion in FY2023. Net income attributable to equity holders was EUR7.813 billion in FY2025, up from EUR5.560 billion in FY2024.
Competitive Position
Sanofi competes with Roche, Novartis, Pfizer, AstraZeneca, GSK, Merck, and Johnson & Johnson. Its strongest positioning is in immunology, rare diseases, vaccines, and selected specialty-care markets where clinical differentiation and manufacturing depth matter.
